The Prostate · 2026
Toward a Modern Telehealth Follow-Up Routine for Radical Prostatectomy: Introducing a Novel E-Health Application for Outcome and Complication Assessment.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bauer Nora, Fankhauser Christian Daniel, Sigg Silvan, Kaufmann Ernest, Affentranger Andres, Aschwanden Fabian, Müller Simone, Hofstetter Brigitte, Baumeister Philipp, Grossmann Nico, Mattei Agostino, Würnschimmel Christoph
Аннотация
BACKGROUND: To implement "MeinLUKS," an automated e-health follow-up system within the EPIC MyChart portal after radical prostatectomy (RP), and to examine factors influencing portal adoption, as well as functional and oncological outcome differences between users and non-users.
METHODS: We retrospectively analyzed men undergoing RP at a tertiary center (January/2022-October/2023). Patients were classified as "users" if they submitted follow-up data via MeinLUKS or "non-users" if monitored through referring physicians. Sociodemographic, clinical, functional, and oncological outcomes were retrieved from institutional registries and included standardized patient-reported outcome measures. Both groups were invited to structured telephone interviews addressing barriers and facilitators of adoption.
RESULTS: Of 274 patients, 128 (47%) used MeinLUKS and 146 (53%) relied on traditional follow-up. Users were younger, more educated, and often urban residents, while oncological characteristics were comparable. Median time to no pad use was not different (11 vs. 28 days, p = 0.3) with similar long-term continence (79% vs. 73% pad-free, p = 0.3). Patient reported sexual function recovery was better among users (56% vs. 36%, p = 0.01). MeinLUKS automatically flagged two biochemical recurrences and unreported complications not identified in routine care. Among 91 interviewees, users emphasized organizational benefits and digital competence, while non-users cited poor onboarding, limited physician advocacy, and interface complexity. Limitations include single-center, retrospective design and non-randomized comparisons.
CONCLUSIONS: Automated e-health follow-up improved data completeness, reduced workforce demands, and detected clinically relevant events missed in routine care. Optimizing onboarding, clinician engagement, and usability may increase adoption and enhance quality and efficiency in prostate cancer survivorship care.
METHODS: We retrospectively analyzed men undergoing RP at a tertiary center (January/2022-October/2023). Patients were classified as "users" if they submitted follow-up data via MeinLUKS or "non-users" if monitored through referring physicians. Sociodemographic, clinical, functional, and oncological outcomes were retrieved from institutional registries and included standardized patient-reported outcome measures. Both groups were invited to structured telephone interviews addressing barriers and facilitators of adoption.
RESULTS: Of 274 patients, 128 (47%) used MeinLUKS and 146 (53%) relied on traditional follow-up. Users were younger, more educated, and often urban residents, while oncological characteristics were comparable. Median time to no pad use was not different (11 vs. 28 days, p = 0.3) with similar long-term continence (79% vs. 73% pad-free, p = 0.3). Patient reported sexual function recovery was better among users (56% vs. 36%, p = 0.01). MeinLUKS automatically flagged two biochemical recurrences and unreported complications not identified in routine care. Among 91 interviewees, users emphasized organizational benefits and digital competence, while non-users cited poor onboarding, limited physician advocacy, and interface complexity. Limitations include single-center, retrospective design and non-randomized comparisons.
CONCLUSIONS: Automated e-health follow-up improved data completeness, reduced workforce demands, and detected clinically relevant events missed in routine care. Optimizing onboarding, clinician engagement, and usability may increase adoption and enhance quality and efficiency in prostate cancer survivorship care.